Skip to content
Nonprofiteer
← ALZHEIMERS DRUG DISCOVERY FOUNDATION

Form 990 for tax year 2024

Filed by ALZHEIMERS DRUG DISCOVERY FOUNDATION.

What the amendment changed

Compared with the return it replaced , filed 11 November 2025. matched by us Only the return's totals, a 990-PF's accounting method and the names listed in Part VII (Part VIII on a 990-PF) are compared. We relate returns by organization, tax year and form, and order them by each return's own timestamp; the filer's own "amended return" checkbox is a separate fact.

Those are the same on the two returns, so the amendment changed something else.

Totals

Total revenue
$47,282,987
Total expenses
$88,250,427
Contributions and grants received
$36,045,158
Grants paid
$73,252,232
Program service revenue
$5,841,351
Investment income
$5,534,433
Other revenue
-$137,955
Total assets, end of year
$299,394,693
Total liabilities, end of year
$82,417,926
Net assets or fund balances, end of year
$216,976,767
Program services expenses (Part IX)
$81,801,493
Management and general expenses
$2,626,578
Fundraising expenses
$3,822,356
Program service expenses (Part III)
$81,801,493

Program services were 92.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1c · Fundraising events

    $1,846,403

  • 1f · All other contributions, gifts and grants

    $34,198,755

  • 1g · Noncash contributions included above

    $2,467,627

  • 2a · Program service revenue: PRI INCOME

    total $5,841,351 · related or exempt $5,841,351

  • 3 · Investment income

    total $4,100,926 · excluded $4,100,926

  • 7a · Gross sales of assets other than inventory

    securities $9,874,086

  • 7b · Less cost or other basis and sales expenses

    securities $8,440,579

  • 7c · Gain or loss

    securities $1,433,507

  • 7d · Net gain or loss

    total $1,433,507 · excluded $1,433,507

  • 8a · Fundraising events: gross income

    $525,700

  • 8a · Fundraising events: contributions included on line 1c

    $1,846,403

  • 8b · Fundraising events: direct expenses

    $663,655

  • 8c · Net income from fundraising events

    total -$137,955 · excluded -$137,955

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $61,257,996 · program services $61,257,996

  • 3 · Grants to foreign organizations and individuals

    total $11,994,236 · program services $11,994,236

  • 5 · Compensation of officers, directors and key employees

    total $2,228,779 · program services $1,743,933 · management and general $284,183 · fundraising $200,663

  • 7 · Other salaries and wages

    total $5,360,022 · program services $3,195,132 · management and general $834,982 · fundraising $1,329,908

  • 8 · Pension plan contributions

    total $188,323 · management and general $95,393 · fundraising $92,930

  • 9 · Other employee benefits

    total $672,167 · program services $417,019 · management and general $106,085 · fundraising $149,063

  • 10 · Payroll taxes

    total $411,780 · program services $261,031 · management and general $64,362 · fundraising $86,387

  • 11b · Fees: legal

    total $195,563 · program services $195,563

  • 11f · Fees: investment management

    total $98,580 · management and general $98,580

  • 11g · Fees: other

    total $1,491,879 · program services $847,101 · management and general $489,534 · fundraising $155,244

  • 12 · Advertising and promotion

    total $448,188 · program services $191,797 · management and general $89,530 · fundraising $166,861

  • 13 · Office expenses

    total $91,155 · program services $30,814 · management and general $36,631 · fundraising $23,710

  • 14 · Information technology

    total $186,059 · program services $62,896 · management and general $74,769 · fundraising $48,394

  • 16 · Occupancy

    total $419,669 · program services $203,504 · management and general $118,537 · fundraising $97,628

  • 19 · Conferences, conventions and meetings

    total $1,684,982 · program services $1,331,268 · management and general $210,414 · fundraising $143,300

  • 22 · Depreciation, depletion and amortization

    total $41,311 · management and general $41,311

  • 24a · Other expenses: OTHER FUNDRAISING EXP.

    total $1,143,455 · fundraising $1,143,455

  • 24b · Other expenses: MISCELLANEOUS

    total $204,717 · program services $69,203 · management and general $82,267 · fundraising $53,247

  • 24c · Other expenses: PUBLIC RELATIONS

    total $131,566 · fundraising $131,566

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $418,639 · end of year $7,163,054

  • 2 · Savings and temporary cash investments

    beginning of year $39,796,956 · end of year $47,754,709

  • 3 · Pledges and grants receivable

    beginning of year $188,735,033 · end of year $170,715,532

  • 9 · Prepaid expenses and deferred charges

    beginning of year $403,557 · end of year $706,750

  • 10a · Land, buildings and equipment: cost or other basis

    $744,271

  • 10b · Land, buildings and equipment: accumulated depreciation

    $609,537

  • 10c · Land, buildings and equipment, net

    beginning of year $157,807 · end of year $134,734

  • 11 · Investments: publicly traded securities

    beginning of year $92,342,872 · end of year $70,622,086

  • 15 · Other assets

    beginning of year $2,318,664 · end of year $2,297,828

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,790,497 · end of year $3,274,049

  • 18 · Grants payable

    beginning of year $58,002,921 · end of year $75,579,333

  • 19 · Deferred revenue

    beginning of year $1,034,282 · end of year $1,437,114

  • 25 · Other liabilities

    beginning of year $2,355,247 · end of year $2,127,430

  • 27 · Net assets without donor restrictions

    beginning of year $74,577,885 · end of year $64,971,491

  • 28 · Net assets with donor restrictions

    beginning of year $185,412,696 · end of year $152,005,276

Mission and programs · 2024

Mission

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

Activities or mission (Part I)

ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT AND TREAT ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.

  • THE ALZHEIMER'S DRUG DISCOVERY FOUNDATION IS DEDICATED TO RAPIDLY ACCELERATING THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. THE ADDF IS SOLELY FOCUSED ON FUNDING THE DEVELOPMENT OF DRUGS FOR ALZHEIMER'S, EMPLOYING A VENTURE PHILANTHROPY MODEL TO SUPPORT RESEARCH IN ACADEMIA AND THE BIOTECH INDUSTRY.

    Expenses $81,801,493 · Grants $73,252,232 · Revenue $5,841,351

As filed on the 2024 return.

Listed in Part VII

  • Adam Hoffman

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Alice Shure

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Ann Jackson

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Bonnie Englebardt Lautenberg

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Bonnie Pfeifer Evans

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Carol Boulanger

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • David Weinreb

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Gary M Lauder

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Henrik Zetterberg MD PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Howard Fillit MD

    FOUNDING EXEC. DIR. & CHIEF SCIENCE OFF.

    Total calculated
    $1,141,097
    From this org
    $663,174
    From related orgs
    $0
    Other
    $477,923
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $646,686
    Bonus
    $0
    Other
    $16,488
    Deferred
    $449,568
    Nontaxable benefits
    $28,355
    Filer's total
    $1,141,097
  • Julieann Shanahan CFA

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Lanny Edelsohn MD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Laura Steele

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Laurence Leeds Jr

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Leonard Lauder

    CO-CHAIRMAN /GOVERNOR (DECEASED)

    Total calculated
    $0
    Hours/week
    1
  • Miia Kivipelto MD PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Nancy Corzine

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Nancy Goodes

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Niranjan Bose PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Paula Zahn

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Philip Scheltens MD PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Rachid Izzar

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Randal Sandler

    CO-VICE CHAIRMAN & SECRETARY

    Total calculated
    $0
    Hours/week
    1
  • Ric Edelman

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Richard Mohs PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Roberta Diaz Brinton PhD

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Ronald Lauder

    CO-CHAIRMAN /GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Sharon Sager

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Thomas McWilliams

    CO-VICE CHAIRMAN & TREASURER

    Total calculated
    $0
    Hours/week
    1
  • Thomas Smith Jr

    GOVERNOR

    Total calculated
    $0
    Hours/week
    1
  • Karen Harris

    CFO AND HEAD OF MISSION RELATED INV

    Total calculated
    $395,260
    From this org
    $369,039
    From related orgs
    $0
    Other
    $26,221
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $365,871
    Bonus
    $0
    Other
    $3,168
    Deferred
    $13,800
    Nontaxable benefits
    $12,421
    Filer's total
    $395,260
  • Mark Roithmayr

    CEO

    Total calculated
    $692,422
    From this org
    $651,120
    From related orgs
    $0
    Other
    $41,302
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $647,952
    Bonus
    $0
    Other
    $3,168
    Deferred
    $13,800
    Nontaxable benefits
    $27,502
    Filer's total
    $692,422
  • Aaron Burstein

    HEAD OF SEARCH AND EVALUATION

    Total calculated
    $368,084
    From this org
    $314,231
    From related orgs
    $0
    Other
    $53,853
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $312,167
    Bonus
    $0
    Other
    $2,064
    Deferred
    $12,915
    Nontaxable benefits
    $40,938
    Filer's total
    $368,084
  • Eli Shobin

    SENIOR DIRECTOR DXA

    Total calculated
    $270,058
    From this org
    $235,962
    From related orgs
    $0
    Other
    $34,096
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $235,530
    Bonus
    $0
    Other
    $432
    Deferred
    $9,596
    Nontaxable benefits
    $24,500
    Filer's total
    $270,058
  • Jane McIntosh

    CHIEF EXTERNAL AFFAIRS

    Total calculated
    $391,573
    From this org
    $377,792
    From related orgs
    $0
    Other
    $13,781
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $376,688
    Bonus
    $0
    Other
    $1,104
    Deferred
    $13,781
    Nontaxable benefits
    $0
    Filer's total
    $391,573
  • Lakita Cavin

    ATTORNEY, MISSION-RELATED

    Total calculated
    $241,235
    From this org
    $220,246
    From related orgs
    $0
    Other
    $20,989
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $219,142
    Bonus
    $0
    Other
    $1,104
    Deferred
    $8,868
    Nontaxable benefits
    $12,121
    Filer's total
    $241,235
  • Laura Nisenbaum

    EXECUTIVE DIRECTOR, DRUG DEVELOPMENT

    Total calculated
    $479,518
    From this org
    $442,772
    From related orgs
    $0
    Other
    $36,746
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $439,604
    Bonus
    $0
    Other
    $3,168
    Deferred
    $13,800
    Nontaxable benefits
    $22,946
    Filer's total
    $479,518

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 4B
HOWARD FILLIT RECEIVED A CONTRIBUTION TO A 457(F) PLAN FOR $443,178 AND IT IS INCLUDED IN COLUMN (C).

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

  • ALAMAR BIOSCIENCES

    $10,016,094

    ALZHEIMERS RESEARCH

  • C2N DIAGNOSTICS

    $7,025,121

    ALZHEIMERS RESEARCH

  • PHARMATROPHIX

    $5,609,700

    ALZHEIMERS RESEARCH

  • COYA THERAPEUTICS

    $5,000,000

    ALZHEIMERS RESEARCH

  • METRO INTERNATIONAL BIOTECHEDENROC

    $5,000,000

    ALZHEIMERS RESEARCH

  • MODULO BIO INC

    $4,845,794

    ALZHEIMERS RESEARCH

  • ALZHEIMERS RESEARCH

  • AQUINNAH PHARMACEUTICALS

    $2,999,586

    ALZHEIMERS RESEARCH

  • ALZHEIMERS RESEARCH

  • UNIVERSITY OF ARIZONA - HEALTH SCIENCES

    $1,774,201

    ALZHEIMERS RESEARCH

The 10 largest by cash amount. The API serves every itemized grant.

Fundraising and gaming

From Schedule G of this return, as filed.

Had an agreement with a professional fundraiser (line 2a)
Not answered

Fundraising events (Part II)

Part II has at most four columns: the two largest events, the rest together, and the total.

Line Event 1 PALM BEACH Event 2 DC LUNCHEON Other events 6 events Total
Gross receipts (line 1) $721,980 $562,849 $1,087,274 $2,372,103
Less contributions (line 2) $635,340 $463,249 $747,814 $1,846,403
Gross income (line 3) $86,640 $99,600 $339,460 $525,700
Cash prizes (line 4) — — — —
Noncash prizes (line 5) — — — —
Rent and facility costs (line 6) — $46,578 $3,960 $50,538
Food and beverages (line 7) $99,248 $86,279 $420,590 $606,117
Entertainment (line 8) — — $7,000 $7,000
Other direct expenses (line 9) — — — —
Direct expenses (line 10)
$663,655
Net income (line 11)
-$137,955

Activities outside the United States

From Schedule F of this return, as filed.

Offices (line 3c)
0
Employees, agents and contractors (line 3c)
0
Expenditures and investments (line 3c)
$18,451,708

At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.

Activities by region (Part I)

Region Offices Employees Activity Specific services Expenditures
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH $15,048,529
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH $2,772,021
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 GRANTS TO RECIPIENTS ALZHEIMER'S DISEASE RESEARCH $631,158

Grants to organizations, by region (Part II)

The purpose of each grant is not shown.

Region Cash grants Manner of disbursement Noncash assistance Noncash description Valuation
EAST ASIA AND THE PACIFIC $20,700 ELECTRONIC $0 — —
EAST ASIA AND THE PACIFIC $610,458 ELECTRONIC $0 — —
NORTH AMERICA $1,248,521 ELECTRONIC $0 — —
NORTH AMERICA $1,523,500 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $282,600 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $650,000 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $4,998,336 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $2,508,003 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $586,999 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $1,117,740 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $598,253 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $2,165,060 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $297,986 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $725,922 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $899,255 ELECTRONIC $0 — —
EUROPE (INCLUDING ICELAND & GREENLAND) $218,375 ELECTRONIC $0 — —
Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
0
Other grantees (Part II line 3)
16
Transferred property to a foreign corporation during the year (line 1)
No
Had an interest in a foreign trust (line 2)
No
Owned an interest in a foreign corporation (line 3)
No
Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
No
Owned an interest in a foreign partnership (line 5)
No
Had operations in or related to a boycotting country (line 6)
No

Provenance

Return type
form_990
Tax year
2024
Filed
18 September 2026
IRS schema version
2024v5.5
Source object
202632619349300028

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.